No Data
No Data
Sunshine Biopharma Launches a New Generic Prescription Drug
US Manufacturing Index Rises To 43, Highest Since 2020
8-K: SUNSHINE BIOPHARMA REPORTS 2024 THIRD QUARTER RESULTS: YEAR-TO-DATE REVENUES UP 54%
Earnings Flash (SBFM) SUNSHINE BIOPHARMA Reports Q3 Revenue $8.4M
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%
Express News | Sunshine Biopharma Q3 2024 GAAP EPS $(0.94), Sales $8.435M
No Data
No Data
Coach Donnie : Let’s GOOO